Activation of p53-regulated pro-apoptotic signaling pathways in PrP-mediated myopathy

BMC Genomics

Volumn 10, Issue , 2009, Pages

  Liang, Jingjing ^a   Parchaliuk, Debra ^b   Medina, Sarah ^b   Sorensen, Garrett ^b   Landry, Laura ^b   Huang, Shenghai ^a   Wang, Meiling ^a   Kong, Qingzhong ^a   Booth, Stephanie A ^b,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; MUSCLE PROTEIN; MYOCYTE ENHANCER FACTOR 2; PRION PROTEIN; PROTEIN BAX; PROTEIN P53; APOPTOSIS REGULATORY PROTEIN; CELL CYCLE PROTEIN; MDM2 PROTEIN, MOUSE; PROTEIN MDM2;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; DISEASE COURSE; DNA MICROARRAY; DOWN REGULATION; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; MOUSE; MYOPATHY; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MUSCLE DISEASE; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

MUS;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; DOXYCYCLINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MDM2; PRPC PROTEINS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65849350635     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-10-201     Document Type: Article

References (75)

1. Prusiner SB Prions Proc Natl Acad Sci USA 1998, 95(23):13363-13383. 33918 9811807 10.1073/pnas.95.23.13363
2. Hu W Rosenberg RN Stüve O Prion proteins: A biological role beyond prion diseases Acta Neurol Scand 2007, 116:75-82. 10.1111/ j.1600-0404.2007.00868.x 17661791
3. Roucou X LeBlanc AC Cellular prion protein neuroprotective function: implications in prion diseases J Mol Med 2005, 83:3-11. 10.1007/ s00109-004-0605-5 15645198
4. Diarra-Mehrpour M Arrabal S Jalil A Pinson X Gaudin C Pietu G Pitaval A Ripoche H Eloit M Dormont D Chouaib S Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death Cancer Res 2004, 64:719-727. 10.1158/0008-5472.CAN-03-1735 14744790
5. Paitel E Sunyach C Alves da Costa C Bourdon JC Vincent B Checler F Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels J Biol Chem 2004, 279:612-618. 10.1074/jbc.M310453200 14570892
6. Paitel E Fahraeus R Checler F Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation J Biol Chem 2003, 278:10061-10066. 10.1074/ jbc.M211580200 12529324
7. Huang S Liang J Zheng M Li X Wang M Wang P Vanegas D Wu D Chakraborty B Hays AP Chen K Chen SG Booth S Cohen M Gambetti P Kong Q Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice Proc Natl Acad Sci USA 2007, 104:6800-8805. 1871865 17420473 10.1073/pnas.0608885104
8. Caughey B Race RE Ernst D Buchmeier MJ Chesebro B Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells J Virol 1989, 63:175-181. 247670 2562814
9. Harris DA Huber MT van Dijken P Shyng SL Chait BT Wang R Processing of a cellular prion protein: Identification of N- and C-terminal cleavage sites Biochemistry 1993 32 1009 1016 10.1021/bi00055a003 8093841
10. Chen SG Teplow DB Parchi P Teller JK Gambetti P Autilio-Gambetti L Truncated forms of the human prion protein in normal brain and in prion diseases J Biol Chem 1995, 270:19173-19180. 10.1074/jbc.270.32.19173 7642585
11. Taraboulos A Scott M Semenov A Avrahami D Laszlo L Prusiner SB Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform J Cell Biol 1995, 129:121-132. 2120366 7698979 10.1083/jcb.129.1.121
12. Vincent B Paitel E Frobert Y Lehmann S Grassi J Checler F Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons J Biol Chem 2000, 275:35612-35616. 10.1074/ jbc.M004628200 10952979
13. Shmerling D Hegyi I Fischer M Blättler T Brandner S Götz J Rülicke T Flechsig E Cozzio A von Mering C Hangartner C Aguzzi A Weissmann C Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions Cell 1998, 93:203-211. 10.1016/S0092-8674(00)81572-X 9568713
14. Flechsig E Hegyi I Leimeroth R Zuniga A Rossi D Cozzio A Schwarz P Rulicke T Gotz J Aguzzi A Weissmann C Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia EMBO J 2003, 22:3095-3101. 162137 12805223 10.1093/ emboj/cdg285
15. Moore RC Lee IY Silverman GL Harrison PM Strome R Heinrich C Karunaratne A Pasternak SH Chishti MA Liang Y Mastrangelo P Wang K Smit AF Katamine S Carlson GA Cohen FE Prusiner SB Melton DW Tremblay P Hood LE Westaway D Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel J Mol Biol 1999, 292:797-817. 10.1006/jmbi.1999.3108 10525406
16. Li A Sakaguchi S Atarashi R Roy BC Nakaoke R Arima K Okimura N Kopacek J Shigematsu K Identification of a novel gene encoding a PrP-like protein expressed as chimeric transcripts fused to PrP exon 1/2 in ataxic mouse line with a disrupted PrP gene Cell Mol Neurobiol 2000, 20:553-567. 10.1023/A:1007059827541 10930132
17. Rossi D Cozzio A Flechsig E Klein MA Rulicke T Aguzzi A Weissmann C Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain EMBO J 2001, 20:694-702. 145426 11179214 10.1093/emboj/20.4.694
18. Nishida N Tremblay P Sugimoto T Shigematsu K Shirabe S Petromilli C Erpel SP Nakaoke R Atarashi R Houtani T Torchia M Sakaguchi S DeArmond SJ Prusiner SB Katamine S A mouse prion protein transgene rescues mice deficient for the prion protein gene from Purkinje cell degeneration and demyelination Lab Invest 1999, 79:689-697. 10378511
19. Anderson L Rossi D Linehan J Brandner S Weissmann C Transgene-driven expression of the Doppel protein in Purkinje cells causes Purkinje cell degeneration and motor impairment Proc Natl Acad Sci USA 2004, 101:3644-3649. 373516 15007176 10.1073/pnas.0308681101
20. Sunyach C Cisse MA da Costa CA Vincent B Checler F The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation J Biol Chem 2007, 282:1956-63. 10.1074/jbc.M609663200 17121821
21. Paitel E Fahraeus R Checler F Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation J Biol Chem 2003, 278:10061-10066. 10.1074/ jbc.M211580200 12529324
22. Sunyach C Checler F Combined pharmacological, mutational and cell biology approaches indicate that p53-dependent caspase 3 activation triggered by cellular prion is dependent on its endocytosis J Neurochem 2005, 92:1399-407. 10.1111/j.1471-4159.2004.02989.x 15748158
23. Utomo AR Nikitin AY Lee WH Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice Nat Biotechnol 1999, 17:1091-1096. 10.1038/15073 10545915
24. Fischer M Rülicke T Raeber A Sailer A Moser M Oesch B Brandner S Aguzzi A Weissmann C Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie EMBO J 1996, 15:1255-1264. 450028 8635458
25. Storey JD Xiao W Leek JT Tompkins RG Davis RW Significance analysis of time course microarray experiments Proc Natl Acad Sci USA 2005, 102:12837-12842. 1201697 16141318 10.1073/pnas.0504609102
26. Storey JD Tibshirani R Statistical significance for genomewide studies Proc Natl Acad Sci USA 2003, 100:9440-9445. 170937 12883005 10.1073/ pnas.1530509100
27. Leek JT Monsen E Dabney AR Storey JD EDGE: Extraction and analysis of differential gene expression Bioinformatics 2006, 22:507-508. 10.1093/ bioinformatics/btk005 16357033
28. Storey JD Dai JY Leek JT The optimal discovery procedure for large-scale significance testing, with applications to comparative microarray experiments Biostatistics 2007, 8:414-432. 10.1093/biostatistics/kxl019 16928955
29. Black BL Olson EN Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins Annu Rev Cell Dev Biol 1998, 14:167-196. 10.1146/annurev.cellbio.14.1.167 9891782
30. McKinsey TA Zhang CL Olson EN Signaling chromatin to make muscle Curr Opin Cell Biol 2002, 14:763-772. 10.1016/S0955-0674(02)00389-7 12473352
31. Nakagawa O Arnold M Nakagawa M Hamada H Shelton JM Kusano H Harris TM Childs G Campbell KP Richardson JA Nishino I Olson EN Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2 Genes Dev 2005, 19:2066-2077. 1199576 16140986 10.1101/gad.1338705
32. Deval D Mordier S Obled C Bechet D Combaret L Attaix D Ferrara M Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting Biochem J 2001, 360:143-150. 1222211 11696001 10.1042/0264-6021:3600143
33. Lecker SH Jagoe RT Gilbert A Gomes M Baracos V Bailey J Price SR Mitch WE Goldberg AL Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression FASEB J 2004, 18:39-51. 10.1096/fj.03-0610com 14718385
34. Sacheck JM Hyatt JP Raffaello A Jagoe RT Roy RR Edgerton VR Lecker SH Goldberg AL Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases FASEB J 2007, 21:140-1. 10.1096/fj.06-6604com 17116744
35. Deriziotis P Tabrizi SJ Prions and the proteasome Biochim Biophys Acta 2008, 1782:713-722. 18644436
36. Drisaldi B Stewart RS Adles C Stewart LR Quaglio E Biasini E Fioriti L Chiesa R Harris DA Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation J Biol Chem 2003, 278:21732-21743. 10.1074/jbc.M213247200 12663673
37. Fioriti L Dossena S Stewart LR Stewart RS Harris DA Forloni G Chiesa R Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations J Biol Chem 2005, 208:11320-11328. 10.1074/jbc.M412441200
38. Gomes MD Lecker SH Jagoe RT Navon A Goldberg AL Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy Proc Natl Acad Sci USA 2001, 98:14440-14445. 64700 11717410 10.1073/ pnas.251541198
39. Bodine SC Latres E Baumhueter S Lai VK Nunez L Clarke BA Poueymirou WT Panaro FJ Na E Dharmarajan K Pan ZQ Valenzuela DM DeChiara TM Stitt TN Yancopoulos GD Glass DJ Identification of ubiquitin ligases required for skeletal muscle atrophy Science 2001, 294:1704-1708. 10.1126/ science.1065874 11679633
40. Stitt TN Drujan D Clarke BA Panaro F Timofeyva Y Kline WO Gonzalez M Yancopoulos GD Glass DJ The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors Mol Cell 2004, 14:395-403. 10.1016/ S1097-2765(04)00211-4 15125842
41. Sandri M Lin J Handschin C Yang W Arany ZP Lecker SH Goldberg AL Spiegelman BM PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription Proc Natl Acad Sci USA 2006, 103:16260-16265. 1637570 17053067 10.1073/ pnas.0607795103
42. Ryan KM Phillips AC Vousden KH Regulation and function of the p53 tumor suppressor protein Curr Opin Cell Biol 2001, 13:332-337. 10.1016/ S0955-0674(00)00216-7 11343904
43. Kumar A Boriek AM Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: A possible role in Duchenne muscular dystrophy FASEB J 2003, 17:386-396. 10.1096/fj.02-0542com 12631578
44. Chen YW Nagaraju K Bakay M McIntyre O Rawat R Shi R Hoffman EP Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy Neurology 2005, 65:826-834. 10.1212/ 01.wnl.0000173836.09176.c4 16093456
45. Monici MC Aguennouz M Mazzeo A Messina C Vita G Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy Neurology 2003, 60:993-997. 12654966
46. Madden SL Galella EA Riley D Bertelsen AH Beaudry GA Induction of cell growth regulatory genes by p53 Cancer Res 1996, 56:5384-5390. 8968090
47. Oda E Ohki R Murasawa H Nemoto J Shibue T Yamashita T Tokino T Taniguchi T Tanaka N Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis Science 2000, 288:1053-1058. 10.1126/ science.288.5468.1053 10807576
48. Shibue T Takeda K Oda E Tanaka H Murasawa H Takaoka A Morishita Y Akira S Taniguchi T Tanaka N Integral role of Noxa in p53-mediated apoptotic response Genes Dev 2003, 17:2233-2238. 196460 12952892 10.1101/ gad.1103603
49. Nakano K Vousden KH PUMA, a novel proapoptotic gene, is induced by p53 Mol Cell 2001, 7:683-694. 10.1016/S1097-2765(01)00214-3 11463392
50. Villunger A Michalak EM Coultas L Müllauer F Böck G Ausserlechner MJ Adams JM Strasser A p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa Science 2003, 302:1036-1038. 10.1126/science.1090072 14500851
51. Willis SN Adams JM Life in the balance: How BH3-only proteins induce apoptosis Curr Opin Cell Biol 2005 17 617 625 10.1016/j.ceb.2005.10.001 16243507
52. Willis SN Fletcher JI Kaufmann T van Delft MF Chen L Czabotar PE Ierino H Lee EF Fairlie WD Bouillet P Strasser A Kluck RM Adams JM Huang DC Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak Science 2007, 315:856-859. 10.1126/science.1133289 17289999
53. Miyashita T Reed JC Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 1995, 80:293-299. 10.1016/ 0092-8674(95)90513-8 7834749
54. Jost CA Marin MC Kaelin WG Jr p73 is a simian [correction of human] p53-related protein that can induce apoptosis Nature 1997, 389:191-194. 10.1038/38298 9296498
55. Gong JG Costanzo A Yang HQ Melino G Kaelin WG Jr Levrero M Wang JY The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage Nature 1999, 399:806-809. 10.1038/21690 10391249
56. Flores ER Tsai KY Crowley D Sengupta S Yang A McKeon F Jacks T p63 and p73 are required for p53-dependent apoptosis in response to DNA damage Nature 2002, 416:560-564. 10.1038/416560a 11932750
57. Fontemaggi G Kela I Amariglio N Rechavi G Krishnamurthy J Strano S Sacchi A Givol D Blandino G Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses J Biol Chem 2002, 277:43359-43368. 10.1074/jbc.M205573200 12213815
58. Attardi LD Reczek EE Cosmas C Demicco EG McCurrach ME Lowe SW Jacks T PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family Genes Dev 2000, 14:704-718. 316461 10733530
59. Huang J Xu LG Liu T Zhai Z Shu HB The p53-inducible E3 ubiquitin ligase p53RFP induces p53-dependent apoptosis FEBS Lett 2006, 580:940-947. 10.1016/j.febslet.2005.09.105 16427630
60. Martin JF Schwarz JJ Olson EN Myocyte enhancer factor (MEF) 2C: A tissue-restricted member of the MEF-2 family of transcription factors Proc Natl Acad Sci USA 1993, 90:5282-5286. 46700 8506376 10.1073/ pnas.90.11.5282
61. Herms JW Korte S Gall S Schneider I Dunker S Kretzschmar HA Altered intracellular calcium homeostasis in cerebellar granule cells of prion protein-deficient mice J Neurochem 2000, 75:1487-1492. 10.1046/ j.1471-4159.2000.0751487.x 10987828
62. Brini M Miuzzo M Pierobon N Negro A Sorgato MC The prion protein and its paralogue Doppel affect calcium signaling in Chinese hamster ovary cells Mol Biol Cell 2005, 16:2799-2808. 1142425 15788568 10.1091/ mbc.E04-10-0915
63. Fuhrmann M Bittner T Mitteregger G Haider N Moosmang S Kretzschmarr H Herms J Loss of the cellular prion protein affects the Ca2+ homeostasis in hippocampal CA1 neurons J Neurochem 2006, 98:1876-1885. 10.1111/ j.1471-4159.2006.04011.x 16945105
64. de la Monte S Sohn YK Ganju YK Wands JR p53- and CD95-associated apoptosis in neurodegenerative diseases Lab Invest 1998, 78:401-411. 9564885
65. Kitamura Y Shimohama S Kamoshima W Matsuoka Y Nomura Y Taniguchi T Changes of p53 in the brains of patients with Alzheimer disease Biochem Biophys Res Comm 1997, 232:418-421. 10.1006/bbrc.1997.6301 9125193
66. Culmsee C Mattson MP p53 in neuronal apoptosis Biochem Biophys Res Commun 2005, 331:761-777. 10.1016/j.bbrc.2005.03.149 15865932
67. Paitel E Alves da Costa C Vilette D Grassi J Checler F Overexpression of PrPc triggers caspase 3 activation: Potentiation by proteasome inhibitors and blockade by anti-PrP antibodies J Neurochem 2002, 83:208-214. 10.1046/j.1471-4159.2002.01234.x
68. Yuan J Yankner BA Apoptosis in the nervous system Nature 2000, 407:802-809. 10.1038/35037739 11048732
69. Akhtar RS Ness JM Roth KA Bcl-2 family regulation of neuronal development and neurodegeneration Biochim Biophys Acta 2004, 1644:189-203. 10.1016/j.bbamcr.2003.10.013 14996503
70. Li A Barmada SJ Roth KA Harris DA N-terminally deleted forms of the prion protein activate both Bax-dependent and Bax-independent neurotoxic pathways J Neurosci 2007, 27:852-859. 10.1523/JNEUROSCI.4244-06.2007 17251426
71. Nicolas O Gavín R Braun N Ureña JM Fontana X Soriano E Aguzzi A del Río JA Bcl-2 overexpression delays caspase-3 activation and rescues cerebellar degeneration in prion-deficient mice that overexpress amino-terminally truncated prion FASEB J 2007, 21:3107-3117. 10.1096/fj.06-7827com 17494993
72. Fairbairn DW Thwaits RN Holyoak GR O'Neill KL Spongiform encephalopathies and prions: An overview of pathology and disease mechanisms FEMS Microbiol Lett 1994, 123:233-239. 10.1111/ j.1574-6968.1994.tb07230.x 7988907
73. Giese A Groschup MH Hess B Kretzschmar HA Neuronal cell death in scrapie-infected mice is due to apoptosis Brain Pathol 1995, 5:213-221. 10.1111/j.1750-3639.1995.tb00597.x 8520720
74. Lucassen PJ Williams A Chung WC Fraser H Detection of apoptosis in murine scrapie Neurosci Lett 1995, 198:185-188. 10.1016/ 0304-3940(95)11995-9 8552317
75. Gray F Adle-Biassette H Chrétien F Ereau T Delisle MB Vital C Neuronal apoptosis in human prion diseases Bull Acad Natl Med 1999, 183:305-220. 10371778